• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

RAPT Therapeutics, Inc. - Common Stock (NQ:RAPT)

29.34 +0.41 (+1.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 100,646
Open 28.24
Bid (Size) 26.71 (1)
Ask (Size) 37.99 (1)
Prev. Close 28.93
Today's Range 27.75 - 29.50
52wk Range 5.666 - 32.35
Shares Outstanding 34,358,152
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy
September 29, 2025
RAPT on track to initiate trial this year 
From RAPT Therapeutics, Inc.
Via GlobeNewswire
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
August 27, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
+125.0%
+125.0%
1 Month
+66.4%
+66.4%
3 Month
+186.8%
+186.8%
6 Month
+363.9%
+363.9%
1 Year
+109.6%
+109.6%

More News

Read More
RAPT Therapeutics Reports Second Quarter 2025 Financial Results
August 07, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire
There are notable gap-ups and gap-downs in today's session.
July 15, 2025
Via Chartmill
RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
June 23, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
June 13, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire
Rapt Therapeutics Get A Bullish Recommendation On ‘Significant Opportunity’ For Allergy Drug Candidate: Retail Worries About Cash Position
June 05, 2025
Via Stocktwits
Topics ETFs
12 Health Care Stocks Moving In Thursday's After-Market Session
June 05, 2025
Via Benzinga
RAPT Therapeutics to Participate in Upcoming Investor Conferences
June 04, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 27, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 23, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 16, 2025
Via Benzinga
RAPT Therapeutics Reports First Quarter 2025 Financial Results
May 08, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
April 15, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire
RAPT Therapeutics to Participate in Upcoming Investor Conferences
March 07, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire
RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
March 06, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire
RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 09, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire
RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
January 06, 2025
From RAPT Therapeutics, Inc.
Via GlobeNewswire
Futures Slide As Bond Yields Jump To 6 Month High
December 26, 2024
Via Talk Markets
Topics Bonds Commodities Cryptocurrencies
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 26, 2024
Via Benzinga
This Progressive Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday
December 26, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 23, 2024
Via Benzinga
Why RAPT Therapeutics Stock Gained Over 100% On Monday?
December 23, 2024
Via Benzinga
US Stocks Mixed, Dow Tumbles 150 Points
December 23, 2024
Via Benzinga
Topics Stocks
RAPT Therapeutics Announces $150 Million Private Placement
December 23, 2024
From RAPT Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is RAPT Therapeutics, Inc. - Common Stock publicly traded?
Yes, RAPT Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does RAPT Therapeutics, Inc. - Common Stock trade on?
RAPT Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for RAPT Therapeutics, Inc. - Common Stock?
The ticker symbol for RAPT Therapeutics, Inc. - Common Stock is RAPT on the Nasdaq Stock Market
What is the current price of RAPT Therapeutics, Inc. - Common Stock?
The current price of RAPT Therapeutics, Inc. - Common Stock is 29.34
When was RAPT Therapeutics, Inc. - Common Stock last traded?
The last trade of RAPT Therapeutics, Inc. - Common Stock was at 10/17/25 04:00 PM ET
What is the market capitalization of RAPT Therapeutics, Inc. - Common Stock?
The market capitalization of RAPT Therapeutics, Inc. - Common Stock is 1.01B
How many shares of RAPT Therapeutics, Inc. - Common Stock are outstanding?
RAPT Therapeutics, Inc. - Common Stock has 1B shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap